Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis
IntroductionThe critical role played by vascular dysfunction and ineffective angiogenesis in the pathophysiology of systemic sclerosis (SSc) suggests that circulating biomarkers reflecting these alterations may be useful in the clinical evaluation of this patient group. We sought to address this iss...
Saved in:
| Main Authors: | Arduino A. Mangoni, Angelo Zinellu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1450176/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis
by: Angelo Zinellu, et al.
Published: (2024-11-01) -
sCD40 and sCD40L as candidate biomarkers of rheumatic diseases: a systematic review and meta-analysis with meta-regression
by: Angelo Zinellu, et al.
Published: (2025-03-01) -
Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment
by: JingTao Sun, et al.
Published: (2025-06-01) -
A systematic review and meta-analysis of pteridines in mild cognitive impairment and Alzheimer’s disease
by: Arduino A. Mangoni, et al.
Published: (2025-02-01) -
Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia
by: Joanna Gora-Tybor, et al.
Published: (2003-01-01)